Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
40%(4 trials)

Phase Distribution

Ph phase_1
1
10%
Ph phase_2
8
80%
Ph phase_3
1
10%

Phase Distribution

1

Early Stage

8

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
8(80.0%)
Phase 3Large-scale testing
1(10.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(10)

Detailed Status

Completed10

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (10.0%)
Phase 28 (80.0%)
Phase 31 (10.0%)

Trials by Status

completed10100%

Recent Activity

0 active trials
Showing 5 of 10
completedphase_2

Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension

NCT02178098
completedphase_2

A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin Intolerance

NCT01751984
completedphase_2

A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides

NCT01262638
completedphase_3

Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

NCT02666664
completedphase_2

A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia

NCT01779453
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT02178098Phase 2

Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension

Completed
NCT01751984Phase 2

A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin Intolerance

Completed
NCT01262638Phase 2

A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides

Completed
NCT02666664Phase 3

Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

Completed
NCT01779453Phase 2

A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia

Completed
NCT02072161Phase 2

Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy

Completed
NCT02659397Phase 2

A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg

Completed
NCT01941836Phase 2

Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients

Completed
NCT01607294Phase 2

A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes

Completed
NCT01485146Phase 1

A Multiple Ascending Dose Study of ETC-1002 in Healthy Subjects

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10